InnoMedica is a pharmaceutical company specializing in the development of innovative drug delivery systems using nanocarrier technology. They focus on creating targeted therapies for oncology and neurology, addressing the need for effective treatments with reduced side effects. Their operations include GMP manufacturing and CRDMO services, catering to healthcare providers and pharmaceutical companies.
Fribourg
1997
1–10
